Latest news
Evaluating the Future of CAR-T Studies in Systemic Sclerosis - EMJEMJ · Tue, 11 Aug 2026 00:10:31 GMTNavigating evidence-based recommendations for the management of systemic sclerosis - nature.comnature.com · Tue, 04 Aug 2026 18:28:47 GMTMerck’s $11B anti-TL1A bet delivers 1 win, 1 loss in midphase inflammatory disease trials - Fierce BiotechFierce Biotech · Tue, 04 Aug 2026 10:30:00 GMT